Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Cash from Financing Activities of -$414.0 million for Q1 2026, down 989.47% year-over-year from $46.5 million in Q1 2025, and down 37.09% quarter-over-quarter from -$302.0 million in Q4 2025.
Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Cash from Financing Activities for 18 consecutive years, with -$414.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 989.47% year-over-year to -$414.0 million; the TTM figure through Mar 2026 stood at -$2.4 billion (down 227.84% YoY), while the FY2025 annual figure was -$3.6 billion, down 273.31% from the prior year.
- Cash from Financing Activities slipped to -$414.0 million in Q1 2026 per BDX's latest filing, from -$302.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.7 billion in Q1 2024 and bottomed at -$1.9 billion in Q4 2024.
- Historically, Cash from Financing Activities has averaged -$271.2 million across 5 years, with a median of -$534.0 million in 2022.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 427.57% — and 2026, when it plunged 989.47%.
- Becton Dickinson's Cash from Financing Activities stood at -$534.0 million in 2022, then slumped by 61.42% to -$862.0 million in 2023, then plunged by 123.67% to -$1.9 billion in 2024, then jumped by 84.34% to -$302.0 million in 2025, then tumbled by 37.09% to -$414.0 million in 2026.
- Business Quant data shows BDX's Cash from Financing Activities at -$414.0 million in Q1 2026, -$302.0 million in Q4 2025, and -$809.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -67.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -577.00 Mn |
| Jun 30, 2026 | -577.00 Mn |
| Mar 31, 2026 | -414.00 Mn |
| Mar 31, 2026 | -414.00 Mn |
| Dec 31, 2025 | -302.00 Mn |
| Dec 31, 2025 | -302.00 Mn |
| Sep 30, 2025 | -809.00 Mn |
| Sep 30, 2025 | -809.00 Mn |
| Jun 30, 2025 | -842.00 Mn |
| Jun 30, 2025 | -842.00 Mn |
| Mar 31, 2025 | -38.00 Mn |
| Mar 31, 2025 | -38.00 Mn |
| Dec 31, 2024 | -1.93 Bn |
| Dec 31, 2024 | -1.93 Bn |
| Sep 30, 2024 | 124.00 Mn |
| Sep 30, 2024 | 124.00 Mn |
| Jun 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.12 Bn |
| Mar 31, 2024 | 1.71 Bn |
| Mar 31, 2024 | 1.71 Bn |